Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
53/100
Pipeline Velocity
27/100
Trial Completion Rate
88/100
Pipeline Concentration
38/100
Pipeline Freshness
79/100
Strategic Signals
Activity
Last 14 days
A Brief, Task-shifted Treatment to Improve Father Depression and Child Outcomes in Kenya: A Pilot Effectiveness-implementation Trial
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida
Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)